Biomarkers in Down syndrome can help us understand Alzheimer's disease

Lancet. 2020 Jun 27;395(10242):1951-1953. doi: 10.1016/S0140-6736(20)30916-8.

Authors

Elizabeth Head¹, Beau Ances²

Affiliations

¹ Department of Pathology and Laboratory Medicine, University of California, Irvine, CA 92697, USA. Electronic address: [email protected].
² Department of Neurology, Washington University, St Louis, MO, USA.

PMID: 32593327
DOI: 10.1016/S0140-6736(20)30916-8

No abstract available

Publication types

Comment

MeSH terms

Adult
Alzheimer Disease*
Amyloid beta-Peptides
Biomarkers
Cross-Sectional Studies
Down Syndrome*
Humans

Substances

Amyloid beta-Peptides
Biomarkers